Iovance Biotherapeutics Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.69 (market cap $6.04B), while Revolution Medicines Inc. Common Stock trades at $189.4 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.7× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IOVA | RVMD | |
|---|---|---|
Market Cap | $6.04B | $40.32B |
Volume | 14,805,993 | 4,855,734 |
Sector | Health | Health |
52-Week High | $14.82 | $221.15 |
52-Week Low | $1.81 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →